ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005

Breast Cancer Awareness High, Knowledge Of Facts Low,

October 5, 2007

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Pryor Bill Embodies Drug Company Fears

July 8, 1994

Letter To the Editor; Closed Meetings Create Aura of Suspicion

August 12, 1994

Funding Opportunities Listed (12-page issue).

July 11, 2003